Assembly Biosciences, Inc.   NASDAQ (ASMB)

2.35    $0.03   1.29%
At close   Friday, Nov 26 04:00 PM

Assembly Biosciences, Inc. Chart

ASMB Stock Price Today

Assembly Biosciences, Inc. (ASMB) stock rallied over 1.29% intraday to trade at $2.35 a share on NASDAQ. The stock opened with a gain of 1.29% at $2.35 and touched an intraday high of $2.4000, rising 3.45% against the last close of $2.32. The stock went to a low of $2.2600 during the session.

Stock Snapshot

2.32
Prev. Close
2.35
Open
116.37M
Market Cap
45.57M
Number of Shares
2.2600
day Low
2.4000
Day High
2.35
-
P/E ratio
3.46%
Free Float in %
-2.66
EPS (TTM)
4.93
Book Value per Share
3.65
Cash Flow per Share
727905
Volume

Assembly Biosciences, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-26$2.35$2.35$2.40$2.26729,200
2021-11-24$2.28$2.32$2.35$2.256,495,400
2021-11-23$2.25$2.29$2.32$2.19879,200
2021-11-22$2.36$2.25$2.36$2.25859,600
2021-11-19$2.38$2.30$2.41$2.28827,900
2021-11-18$2.51$2.38$2.51$2.302,286,400
2021-11-17$2.62$2.49$2.62$2.471,106,500
2021-11-16$2.78$2.60$2.78$2.571,960,200
2021-11-15$2.85$2.81$2.86$2.77846,700
2021-11-12$2.94$2.90$3.02$2.871,529,600
2021-11-11$2.93$2.89$2.95$2.842,199,700

Contact Details

331 Oyster Point Boulevard
Fourth Floor
South San Francisco, CA 94080
United States
http://www.assemblybio.com
833 509 4583

Company Information

Employees139
Beta0.62
Sales or Revenue7.30M
5Y Sales Change-%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. It also has a clinical collaboration agreement with Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.

Frequently Asked Questions

What is the current Assembly Biosciences, Inc. (ASMB) stock price?

Assembly Biosciences, Inc. (NASDAQ: ASMB) stock price is $2.35 as of the last check on Friday, Nov 26. During the trading session, ASMB stock reached the peak price of $2.4000 while $2.2600 was the lowest point it dropped to.

ASMB's industry and sector of operation?

The NASDAQ listed ASMB is part of Biotechnology industry that operates in the broader Healthcare sector. Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States.

Who are the executives of ASMB?

Dr. John G. McHutchison A.O., M.D., FRACP
CEO, Pres & Director

Mr. Michael P. Samar
CFO & Principal Accounting Officer

Dr. Luisa M. Stamm M.D., Ph.D.
Chief Medical Officer

Dr. Uri A. Lopatin
Co-Founder and Clinical & Scientific Advisor


What is the ASMB stock price today?

ASMB stock traded closed the last session at $2.35, which is $0.03 or 1.29% higher than its previous close of $2.32. ASMB's current trading price is -66.52% lower than its 52-week high of $7.02 where as its distance from 52-week low of $2.19 is 7.31%.

How many employees does ASMB have?

Number of ASMB employees currently stands at 139. ASMB operates from 331 Oyster Point Boulevard Fourth Floor South San Francisco, CA 94080 United States.

Link for ASMB official website?


How do I contact ASMB?

ASMB could be contacted at 331 Oyster Point Boulevard Fourth Floor South San Francisco, CA 94080 United States, or at phone # 833 509 4583 and can also be accessed through its website: http://www.assemblybio.com

How many shares of ASMB are traded daily?

ASMB stock volume for the day was 727905 shares while in the previous session number of ASMB shares traded was 729200. The average number of ASMB shares traded daily for last 3 months was 837690.

How much did ASMB change today?

The percentage change in ASMB stock occurred in the recent session was 1.29% while the dollar amount for the price change in ASMB stock was $0.03.

What price range ASMB stock been trading in?

In the recent session, the day high for ASMB stock was $2.4000 while the low for ASMB stock touched on the day was $2.2600.

What is the market cap of ASMB currently?

The market value of ASMB currently stands at $116.37M with its latest stock price at $2.35 and 45.57M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam